Skye Bioscience, Inc. Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31)
Skye Bioscience, Inc. (SKYE) reported Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) of 3.62 million shares for the 44-month period ending 2014-10-31, per its 10-Q filed 2014-09-15.
Discontinued › Notes
us-gaap:StockIssuedDuringPeriodSharesIssuedForCash · last filed 2014-09-15
- 2014-10-31: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 44 month 3.62M shares.
- 2013-10-31: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 32 month 3.62M shares.
- 2013-07-31: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 29 month 3.15M shares.
- 2013-04-30: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 25 month 3.15M shares.
| Period end | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 25 month | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 29 month | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 32 month | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 44 month |
|---|---|---|---|---|
| 2014-10-31 | 3.62M shares 10-Q · filed 2014-09-15 | |||
| 2013-10-31 | 3.62M shares 10-Q · filed 2014-03-17 | |||
| 2013-07-31 | 3.15M shares 10-Q · filed 2013-09-16 | |||
| 2013-04-30 | 3.15M shares 10-Q · filed 2013-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |